An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. - Wikidata - awgldk - TriplyDB

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

http://www.wikidata.org/entity/Q37053079

about

Pancreatic Cancer from Molecular Pathways to Treatment Opinion Echoes of the embryo: using the developmental biology toolkit to study cancer Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs Differentiation and transdifferentiation potentials of cancer stem cells Applications of iPSCs in Cancer Research Induced pluripotent stem cell technology for dissecting the cancer epigenome Advances in cellular technology in the hematology field: What have we learned so far?Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle Distinctive properties of metastasis-initiating cells Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells Technologies In vitro models of cancer stem cells and clinical applications Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology Regulation of Cellular Identity in Cancer Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells.Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming.Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue.Human stem cells for craniomaxillofacial reconstruction.Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture Investigating human disease using stem cell models.Organoid models of human and mouse ductal pancreatic cancer Reprogramming of human cancer cells to pluripotency for models of cancer progression The crossroads between cancer stem cells and aging.Preclinical models of pancreatic ductal adenocarcinoma.HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.Modeling pancreatic cancer with organoids Human induced pluripotent stem cells from basic research to potential clinical applications in cancer Induced pluripotency for translational research Pancreatic cancer metastasis: are we being pre-EMTed?Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells.Using induced pluripotent stem cells as a tool for modelling carcinogenesis.Crosstalk between stem cell and cell cycle machineries.Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.Patient-derived induced pluripotent stem cells in cancer research and precision oncology.Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer.Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.

P2860

Q26743482-89BCA01F-FABE-4693-A337-B3C35CA7C456 Q26770157-2A3A40F2-9C85-4841-B5CD-BDEC910D9785 Q26774942-9440B7F3-64CA-41DD-8A3C-E7D7116D645F Q26775061-326E6885-2C85-4566-BD8A-1F210E3D663A Q26775122-34D2CE9D-6561-42FF-B933-D4A8E9A6286E Q26782242-C095C1F7-4807-40EF-AD21-544E5C7993E2 Q26798036-35EB01A3-C170-49B0-8D44-58E2C1378E44 Q26801711-B9776788-6A02-435B-B532-BD1C2B4FDF9C Q26853179-8769EF48-95CD-47E6-A5A4-B1CB2C3E8E2C Q27331430-9FA8F8AE-3FC0-4E6A-9C88-EA09281D3E64 Q28069801-2A2B60B2-15C7-461F-98EC-88DAAE2AC53C Q28071879-23504E52-CB44-4401-89E4-4BC9F1204628 Q28076101-F0F780E6-0154-4539-9B92-EC7E90DEFE99 Q28079356-0D0B7B07-E08D-4388-BE47-15F55232A513 Q28080945-C9E2292F-570A-45AF-8CB6-30BD62585FDD Q28086849-9E9BA620-BDC8-48B7-A989-05154436C7DB Q30841369-34F93178-700E-489F-A82E-6603A1CE9DFC Q33566486-63773E1F-033D-4871-B7B4-5C0FB91FB44C Q33716184-E1EE8A7B-E779-4F97-B5D7-2657EC02117D Q33788845-EA19B493-9F37-4747-8768-6DE65E07522F Q33865017-A4EF3DF9-A777-43F9-BE02-5E725E428EB3 Q34431170-EEB8587B-D268-4CC2-980D-FB5A890A2DAE Q34456438-EA0D51F5-34B1-4532-A65E-916175235F01 Q35204997-2B8955F0-C293-463A-A748-6DE58CA1AB1F Q35566484-B1E0AAFB-E613-4F05-8643-0A4A4A72D8E8 Q36428208-8EBC136D-50B9-4A85-B2FF-8A474B10DFE2 Q36475493-9AF248D9-6B73-42B6-991D-C3C137BE57DD Q36689002-C278E00A-5A83-464C-A942-17AB5632A938 Q36842030-7B2514C3-7EBE-4D96-BC02-9E611F130545 Q37316328-A8D22948-FDFA-4E6C-B0F0-B678C980846D Q38140541-8B526AED-D76B-4684-A3F9-97A715F14AEC Q38288556-920058E3-0A72-4F24-BB26-48DED2D55C78 Q38297935-7BA03DE0-305F-496E-A15F-B0B6571AEC5B Q38342378-ED13188E-67D5-4FAB-B246-B1C06C12441A Q38393195-AB36A2C0-745A-451E-916A-64B1088F61BA Q38621243-FF221652-178E-423A-AC12-E65CD23E1E2F Q38682057-E6166A9B-A5E7-42F1-9EE5-81D701C3EF2E Q38786566-EA04A418-6E3B-4745-A752-3F10F1FBCAC9 Q38803510-919DDEAB-6133-47EB-9AA5-D878892B5B8D Q38866525-15E573B3-A332-4753-9BAA-26C8360548A5

P2860

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

http://www.wikidata.org/entity/Q37053079

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An iPSC line from human pancre ...... pancreatic cancer progression.

@en

An iPSC line from human pancre ...... pancreatic cancer progression.

@nl

type

label

An iPSC line from human pancre ...... pancreatic cancer progression.

@en

An iPSC line from human pancre ...... pancreatic cancer progression.

@nl

prefLabel

An iPSC line from human pancre ...... pancreatic cancer progression.

@en

An iPSC line from human pancre ...... pancreatic cancer progression.

@nl

P1433

Q37053079-27AA08FF-721A-41A6-AD22-2AF36F727A32

P1476

Q37053079-4FEFC72A-A168-4DBA-98C4-CD887FCB423A

P2093

Q37053079-12F2EB8B-2793-4FD8-85BB-F4BFCC8448DA

Q37053079-1CE01DE3-CE0D-4FFE-8CE5-9D9F3D86B2D9

Q37053079-24A2BADC-75C3-4401-AAA5-8AD1EA968CE3

Q37053079-409C4C0C-F22E-4161-8919-28BCAC737F53

Q37053079-44C1B1A9-D41A-4529-9FF4-80629436C349

Q37053079-4E1917E6-B1B9-4707-A8C5-B3E2F2B069C1

Q37053079-74F6BE33-47D8-4616-B95B-C3E84CB8021E

Q37053079-9904E4D2-8FDB-4F25-B316-335BF0C3898C

Q37053079-CFA61DF7-8EB0-4A48-A15F-35B08401A74C

Q37053079-E2DA11C8-31AD-47FC-838A-E5B59C16E237

P2860

Q37053079-0272A915-FC7A-46AD-8286-6187E5B8595C

Q37053079-04836C1A-3EAB-4CC6-814A-6293C7759D6C

Q37053079-18FC4BB6-B25D-45E3-B7B3-FCDAFDF57449

Q37053079-1CF62664-89D0-4B62-9436-658CCA7CDB79

Q37053079-23AC60ED-8FAA-4023-88DB-45EFD8D6113E

Q37053079-2AB13DC1-33B6-4867-BF43-09952C9444A4

Q37053079-3180C50F-CC1F-4CDD-BD68-1AC857C7E83C

Q37053079-35D329B5-69E0-4E40-BC9A-DF7F196DB908

Q37053079-36C19DD5-93F8-4EBD-9CF0-73CD448C1274

Q37053079-37666694-AB08-4667-BD44-716453137DED

P304

Q37053079-B9CB9B0B-7F4E-4940-AAFD-1A99E308E268

P31

Q37053079-BC2E6C95-BDBD-49E3-ABA7-42398AE6791E

P356

Q37053079-75F987B5-E351-45A7-872D-453241B820B8

P433

Q37053079-35401970-682A-4A2C-9692-BD74829FE0B6

P478

Q37053079-FCF1D814-B038-484D-9917-45BDE1EB619F

P50

Q37053079-65891967-7146-47C6-9184-21FDC5BF99BD

Q37053079-A97AE5F2-65EB-48FD-93E8-769596796088

P577

Q37053079-C0C478AB-6615-488E-A804-1AECDE38B3B2

P5875

Q37053079-FCA5D627-200F-4B5D-A0AD-0DCC4F091C95

P698

Q37053079-DC1AA138-A92B-4B6D-9DAA-A5CFD82B6D92

P921

Q37053079-D8DD1235-8C34-422C-9ECD-C6810D98BC2C

P932

Q37053079-311BC7CC-839F-4EE5-A87A-E302F5582945

P356

J.CELREP.2013.05.036

P1433

P1476

An iPSC line from human pancre ...... pancreatic cancer progression

@en

P2093

Andrew A Gumbs

http://www.w3.org/2001/XMLSchema#string

Andrew D Rhim

http://www.w3.org/2001/XMLSchema#string

Antonia R Sepulveda

http://www.w3.org/2001/XMLSchema#string

Ben Z Stanger

http://www.w3.org/2001/XMLSchema#string

Chao-Xing Yuan

http://www.w3.org/2001/XMLSchema#string

Emma E Furth

http://www.w3.org/2001/XMLSchema#string

Greg Donahue

http://www.w3.org/2001/XMLSchema#string

Jessica Sands

http://www.w3.org/2001/XMLSchema#string

John P Hoffman

http://www.w3.org/2001/XMLSchema#string

Kenneth S Zaret

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Control of pancreas and liver gene expression by HNF transcription factors

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

Identification of pancreatic cancer stem cells

Cancer epigenomics: DNA methylomes and histone-modification maps

EMT and dissemination precede pancreatic tumor formation

P304

2088-2099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2013.05.036

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241691829

http://www.w3.org/2001/XMLSchema#string

P698

23791528

http://www.w3.org/2001/XMLSchema#string

P921

P932

3726210

http://www.w3.org/2001/XMLSchema#string